WARNING: CDC Issues Alert Over ‘Cluster of Illnesses’ Tied to Tianeptine Products – FDA Investigating Severe Adverse Events

Trenton, New Jersey – The Centers for Disease Control and Prevention (CDC) issued a warning regarding a “cluster of illnesses” linked to a drug called tianeptine, commonly found in various products.

In a span of five months, from June to November 2023, the CDC reported 20 cases of tianeptine use in 17 individuals in New Jersey. This increase was described as an “uncharacteristic spike” in comparison to the usual two or fewer exposures reported by the poison center each year.

Most of the cases involved patients who ingested tianeptine from a product called Neptune’s Fix, a flavored elixir shot that was recently recalled. In response, Neptune Resources voluntarily recalled Fix Elixir, Fix Extra Strength Elixir, and Fix Tablets after discovering the presence of tianeptine, which is not FDA-approved for any medical use.

According to George Karavetsos, an attorney and former director of the FDA’s Office of Criminal Investigations, tianeptine has gained the nickname “gas station heroin” due to its potential dangers. He also cautioned about companies making unproven medical claims about the drug’s ability to improve brain function and treat various conditions such as anxiety, depression, and pain.

The FDA has continued to receive severe adverse event reports related to Neptune‘s Fix products, including seizures, loss of consciousness, and death. The agency also warned about potential life-threatening interactions with other medications consumers may be taking.

Furthermore, the CDC highlighted the easy accessibility of tianeptine in elixir formulations, available for purchase online, as well as in gas stations and convenience stores. The FDA also sent a letter to retailers urging them to stop selling Neptune’s Fix and any other tianeptine-containing products following multiple reports of serious medical injuries.

The issue raises concerns about the availability and use of unapproved drugs in the market, emphasizing the need for stricter regulations and consumer awareness regarding such products. As health authorities continue to investigate the implications of tianeptine use, the public is encouraged to exercise caution and seek guidance from healthcare professionals when considering medications and supplements.